Ye Leng
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
-
- RNA modifications and cancer
- Histone Deacetylase Inhibitors Research
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
- Protein Degradation and Inhibitors
- RNA Research and Splicing
Papers in
-
- Epigenetics and DNA Methylation 6
- Histone Deacetylase Inhibitors Research 4
- Genomics and Chromatin Dynamics 3
- Pluripotent Stem Cells Research 2
- Renal and related cancers 2
- Oncology 4
- Drug Transport and Resistance Mechanisms 2
- Co-authors
- Jiuhong Kang (10 shared papers)Guiying Wang (5 shared papers)Songcheng Zhu (6 shared papers)Jun Liu (1 shared paper)Jian Wang (1 shared paper)Changxing Lv (1 shared paper)Wenwen Jia (5 shared papers)Jiajie Xi (4 shared papers)
- Journals
- Oncotarget (2 papers)Journal of Biological Chemistry (2 papers)DNA and Cell Biology (1 paper)Biochemical and Biophysical Research Communications (1 paper)Oncogene (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Ye Leng
21 papers receiving 798 citations
Peers
Comparison fields: 5 of 82
- Cancer Research 193
- Molecular Biology 540
- Oncology 131
- Immunology 77
- Geriatrics and Gerontology 10
Countries citing papers authored by Ye Leng
This map shows the geographic impact of Ye Leng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye Leng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye Leng more than expected).
Fields of papers citing papers by Ye Leng
This network shows the impact of papers produced by Ye Leng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye Leng. The network helps show where Ye Leng may publish in the future.
Co-authors
The 25 scholars most cited alongside Ye Leng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 221 | |
| 2 | 2013 | 124 | |
| 3 | 2013 | 109 | |
| 4 | 2018 | 77 | |
| 5 | 2016 | 51 | |
| 6 | 2011 | 44 | |
| 7 | 2012 | 42 | |
| 8 | 2011 | 39 | |
| 9 | 2019 | 36 | |
| 10 | 2013 | 22 | |
| 11 | 2014 | 10 | |
| 12 | 2011 | 7 | |
| 13 | 2010 | 6 | |
| 14 | 2015 | 6 | |
| 15 | [Elastic modulus of small intestinal submucosa]. | 2006 | 5 |
| 16 | Establishment of HPLC-ESI-MS method for the determination of eplerenone in human plasma and its pharmacokinetics. | 2009 | 5 |
| 17 | 2017 | 4 | |
| 18 | 2025 | 1 | |
| 19 | 2024 | 1 | |
| 20 | Cell cycle analysis by cyclin E + A/DNA multiparameter flow cytometry in exponential growth MOLT-4 cells. | 2001 | 1 |
About Ye Leng
Ye Leng is a scholar working on Molecular Biology, Oncology, Spectroscopy, Immunology and Economics and Econometrics, having authored 22 papers that have together received 812 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (6 papers), Histone Deacetylase Inhibitors Research (4 papers), Genomics and Chromatin Dynamics (3 papers), Analytical Chemistry and Chromatography (3 papers), Pluripotent Stem Cells Research (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Renal and related cancers (2 papers) and Immune cells in cancer (2 papers). The work is most often cited by research in Cancer Research (193 citations), Molecular Biology (540 citations), Oncology (131 citations), Immunology (77 citations) and Geriatrics and Gerontology (10 citations). Ye Leng has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Jiuhong Kang, Guiying Wang, Songcheng Zhu, Jun Liu, Jian Wang, Changxing Lv, Wenwen Jia, Jiajie Xi, Dan Ye and Ping Chen. Their work appears in journals such as Oncotarget, Journal of Biological Chemistry, DNA and Cell Biology, Biochemical and Biophysical Research Communications and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.